
Keywords: AHDS; Allan-Herndon-Dudley syndrome; Axin2; Axis inhibition protein 2; APC; adenomatous polyposis coli; BMP; Bone morphogenetic protein; CNP; 2â²,3â²-cyclic nucleotide 3â²-phosphodiesterase; CNS; Central nervous system; D2/3; Deiodinases 2 and 3; E; Em